Seedcorn Awards

Seedcorn awards help researchers to generate high-quality preliminary data to advance innovative and novel ideas with the potential to transform the prevention, diagnosis and/or treatment of human diseases.

We are looking for impactful,  'out-of-the-box' ideas. Applicants should have a novel and innovative hypothesis and some preliminary data that can be developed further. We prioritise exciting ideas with the greatest potential to secure further funding and grants. We will consider both pre-clinical and clinical research studies.

At the end of the funding period, continuation funding may be available for successful projects.

Seedcorn awards provide £10K funding over 12 - 18 months. For clinical studies requiring patient recruitment, we will consider  a maximum of £15K over 18 months. Clinical studies requiring patient recruitment between 12-18 months will be funded pro rata.

Contact
For general enquiries regarding eligibility and the application process, please contact Richard Miller (rmiller@rosetreestrust.co.uk).

To apply, please visit the Rosetrees Flexigrant Portal.

Submission period opening

1st July 2023

Submission period closing

31st August (5pm) 2023

Notification of funding decision

Jan 2024

Grant duration

Pre-clinical studies: 12 months
Clinical studies: Up to 18 months

Funding amount

Pre-clinical studies: Up to £10K
Clinical studies: Up to £15K

Funding

  • Seedcorn awards provide up to £10K funding over 12 months for pre-clinical studies. For clinical studies requiring patient recruitment, we will consider applications for £15K over 18 months.
  • Funding is flexible and can be used to fund researcher salaries, research consumables and other related research costs.

Eligibility

  • Seedcorn grants are open to researchers of all levels and we encourage applications from early-career researchers with innovative ideas.
  • All applicants must confirm that they are fully funded for the duration of the research project.

Evaluation process

  • All applications will be initially checked for eligibility. An initial triage by an internal scientific panel will select the best applications that will be taken forward for external review. Triage will be based on the scientific quality, clinical need, track record of research team, innovation and potential for further development and clinical translation. Selected applications will then be sent for external review. The best scored applications will be shortlisted and considered by a scientific panel who will make funding recommendations.
  • The final funding decision will be subject to internal approval.

Contact

For general enquiries regarding eligibility and the application process, please contact Richard Miller (rmiller@rosetreestrust.co.uk).